Practical Geriatrics ›› 2026, Vol. 40 ›› Issue (10): 997-1005.doi: 10.3969/j.issn.1003-9198.2026.10.005

Previous Articles     Next Articles

Mechanism of 11β-HSD1 inhibition in alleviating palmitic acid-induced reactive astrocyte activation

WEI Liqin, QIN Li, LI Guochao, ZHUANG Mengping, ZHANG Yumin, LIU Juan   

  1. Department of Geriatric Endocrinology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
  • Received:2026-05-01 Published:2026-10-23
  • Contact: LIU Juan, Email: lioujane@njmu.edu.cn

Abstract: Objective To investigate the molecular mechanism by which inhibition of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) alleviates palmitic acid-induced reactive astrocyte activation. Methods Primary astrocytes were isolated from the hippocampal tissue of neonatal rats and cultured in vitro. The cells were divided into a control group, a palmitic acid group, a palmitic acid + BVT.2733 treatment group, and a palmitic acid-treated 11β-HSD1 knockout cell group. Transmission electron microscopy, immunofluorescence, reverse transcription quantitative real-time PCR (RT-qPCR), and Western blot were used to evaluate cellular ultrastructure, morphology, and the expression levels of relevant genes and proteins. Transcriptome sequencing and bioinformatics analysis were performed to screen for differentially expressed genes and pathways. Results Palmitic acid induced the conversion of astrocytes into the A1 reactive phenotype, and activated the nuclear factor Kappa-B (NF-κB) mediated inflammatory signaling pathway(P<0.05). Knockout of the 11β-HSD1 gene or treatment with BVT.2733 significantly ameliorated palmitic acid-induced ultrastructural damage, inhibited A1 phenotype conversion, and attenuated the inflammatory response(P<0.05). Transcriptome sequencing and gene set enrichment analysis (GSEA) suggested that the NF-κB-mediated signaling pathway may serve as a key downstream pathway by which 11β-HSD1 regulated astrocyte function. Conclusions Inhibition of 11β-HSD1 can alleviate ultrastructural damage, inhibit A1 conversion, and attenuate the inflammatory response in astrocytes, which may serve as a potential target for the intervention of obesity-associated cognitive dysfunction.
   

Key words: astrocytes, 11β-hydroxysteroid dehydrogenase type 1, obesity-related cognitive impairment, inflammation, endoplasmic reticulum stress

CLC Number: